Reference is made to stock exchange notice of 4 November 2016 regarding increase of the share capital in Targovax ASA (the "Company") relating to exercise of employee options and settlement of restricted stock units. As per 18 November 2016, 56,799 shares each with a par value of NOK 0.10 were subscribed by employees holding vested options. No restricted stock unites were settled and no shares were accordingly subscribed for by any holders of restricted stock units.
The new share capital in the Company will accordingly be NOK 4,219,080. The share capital increase will be registered in the Register of Business Enterprises (NW: Foretaksregisteret) as soon as practically possible.
For further information please contact:
Phone: +47 906 56 525
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Last updated on: 21/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.